Previous Section
Review Articles
31. Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia.
- Author
- Burnett JR; Huff MW;
- Institution
- Royal Perth Hospital, Department of Core Clinical Pathology & Biochemistry, PathWest Laboratory Medicine WA, Wellington Street Campus, GPO Box X2213, Perth, WA 6847, Australia. john.burnett@health.wa.gov.au
- Journal
- Expert Opin Investig Drugs. 2006 Nov;15(11):1337-51.
- Abstract URL
- Click here to view abstract
32. The safety of aggressive statin therapy: how much can low-density lipoprotein cholesterol be lowered?
- Author
- Jacobson TA;
- Institution
- Office of Health Promotion and Disease Prevention, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30303, USA. tjaco02@emory.edu
- Journal
- Mayo Clin Proc. 2006 Sep;81(9):1225-31.
- Abstract URL
- Click here to view abstract
33. Cholesterol management.
- Author
- Griffith K;
- Institution
- Primary Care Cardiovascular Society, USA.
- Journal
- Practitioner. 2006 Sep;250(1686):23-4, 26, 29.
34. Nutriceuticals in cardiovascular disease: psyllium.
- Author
- Petchetti L; Frishman WH; Petrillo R; Raju K;
- Institution
- Department of Medicine, Mt. Vernon Hospital, Mt. Vernon, New York, USA.
- Journal
- Cardiol Rev. 2007 May-Jun;15(3):116-22.
- Abstract URL
- Click here to view abstract
35. Mechanisms of disease: HDL metabolism as a target for novel therapies.
- Author
- Rader DJ;
- Institution
- Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, 654 BRB II/III, 421 Curie Boulevard, Philadelphia, PA 19104, USA. rader@mail.med.upenn.edu
- Journal
- Nat Clin Pract Cardiovasc Med. 2007 Feb;4(2):102-9.
- Abstract URL
- Click here to view abstract
36. Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence.
- Author
- Patch CS; Tapsell LC; Williams PG; Gordon M;
- Institution
- National Centre of Excellence in Functional Foods, Northfields Avenue, University of Wollongong, New South Wales, Australia. cpatch@nceff.com.au
- Journal
- Vasc Health Risk Manag. 2006;2(2):157-62.
- Abstract URL
- Click here to view abstract
37. Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination.
- Author
- Neal RC; Jones PH;
- Institution
- Baylor College of Medicine, Section of Lipid and Atherosclerosis, Houston, TX 77030, USA. rneal@bcm.tmc.edu
- Journal
- Vasc Health Risk Manag. 2006;2(1):31-8.
- Abstract URL
- Click here to view abstract
38. Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem.
- Author
- Hayward RA; Hofer TP; Vijan S;
- Institution
- Department of Veterans Affairs, VA Center for Practice Management and Outcomes Research, VA Ann Arbor Healthcare System, and University of Michigan Schools of Medicine and Public Health, Ann Arbor, Michigan 48113-0170, USA. rhayward@umich.edu
- Journal
- Ann Intern Med. 2006 Oct 3;145(7):520-30.
- Abstract URL
- Click here to view abstract
39. The evolution of European guidelines: changing the management of cholesterol levels.
- Author
- Erhardt LR; Gotto A Jr;
- Institution
- Department of Cardiology, Cardiology Research Unit, University of Lund, Malmo University Hospital, SE-205 02 Malmo, Sweden. leif.erhardt@med.lu.se
- Journal
- Atherosclerosis. 2006 Mar;185(1):12-20. Epub 2005 Nov 23.
- Abstract URL
- Click here to view abstract
40. Plant sterols combined with exercise for the treatment of hypercholesterolemia: overview of independent and synergistic mechanisms of action.
- Author
- Marinangeli CP; Varady KA; Jones PJ;
- Institution
- School of Dietetics and Human Nutrition, McGill University, Quebec, Canada.
- Journal
- J Nutr Biochem. 2006 Apr;17(4):217-24. Epub 2005 Oct 10.
- Abstract URL
- Click here to view abstract
